

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | definitive hemopoiesis (GO:0060216) | 6.58461741 |
| 2 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.66171039 |
| 3 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 5.62233893 |
| 4 | platelet dense granule organization (GO:0060155) | 5.50387440 |
| 5 | mature B cell differentiation involved in immune response (GO:0002313) | 5.47444706 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 5.09533907 |
| 7 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.89325055 |
| 8 | heparin metabolic process (GO:0030202) | 4.81701935 |
| 9 | heparin biosynthetic process (GO:0030210) | 4.81701935 |
| 10 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.71571660 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.66203458 |
| 12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.57827053 |
| 13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.49713179 |
| 14 | phospholipid scrambling (GO:0017121) | 4.46167805 |
| 15 | dopamine transport (GO:0015872) | 4.39350220 |
| 16 | response to interferon-beta (GO:0035456) | 4.36091851 |
| 17 | protein localization to cilium (GO:0061512) | 4.34675865 |
| 18 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.27018116 |
| 19 | kidney mesenchyme development (GO:0072074) | 4.23091277 |
| 20 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.15565898 |
| 21 | mesenchymal cell development (GO:0014031) | 4.08944152 |
| 22 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.04080922 |
| 23 | megakaryocyte development (GO:0035855) | 4.02562931 |
| 24 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.99073263 |
| 25 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.96497692 |
| 26 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.94198388 |
| 27 | Notch signaling involved in heart development (GO:0061314) | 3.93683958 |
| 28 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.92138824 |
| 29 | mature B cell differentiation (GO:0002335) | 3.90462853 |
| 30 | cell migration involved in heart development (GO:0060973) | 3.85800188 |
| 31 | metanephric mesenchyme development (GO:0072075) | 3.84366961 |
| 32 | relaxation of smooth muscle (GO:0044557) | 3.83983831 |
| 33 | dermatan sulfate biosynthetic process (GO:0030208) | 3.80107162 |
| 34 | regulation of vasculogenesis (GO:2001212) | 3.79843140 |
| 35 | daunorubicin metabolic process (GO:0044597) | 3.78835859 |
| 36 | polyketide metabolic process (GO:0030638) | 3.78835859 |
| 37 | doxorubicin metabolic process (GO:0044598) | 3.78835859 |
| 38 | cyclic nucleotide catabolic process (GO:0009214) | 3.77706274 |
| 39 | sulfation (GO:0051923) | 3.72606045 |
| 40 | Peyers patch development (GO:0048541) | 3.72340221 |
| 41 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.72340221 |
| 42 | regulation of dopamine secretion (GO:0014059) | 3.68945178 |
| 43 | negative regulation of platelet activation (GO:0010544) | 3.67854341 |
| 44 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.66756634 |
| 45 | regulation of axon regeneration (GO:0048679) | 3.64919715 |
| 46 | regulation of neuron projection regeneration (GO:0070570) | 3.64919715 |
| 47 | nerve growth factor signaling pathway (GO:0038180) | 3.64351294 |
| 48 | regulation of endothelial cell differentiation (GO:0045601) | 3.56980147 |
| 49 | positive regulation of receptor internalization (GO:0002092) | 3.56571619 |
| 50 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 3.54669400 |
| 51 | neural crest cell development (GO:0014032) | 3.53333413 |
| 52 | renal tubule morphogenesis (GO:0061333) | 3.52387702 |
| 53 | negative regulation of dendrite development (GO:2000171) | 3.52349413 |
| 54 | glutamate receptor signaling pathway (GO:0007215) | 3.52069783 |
| 55 | intracellular pH reduction (GO:0051452) | 3.47616128 |
| 56 | synaptic transmission, glutamatergic (GO:0035249) | 3.45879053 |
| 57 | cAMP catabolic process (GO:0006198) | 3.45779513 |
| 58 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.44844663 |
| 59 | lymph node development (GO:0048535) | 3.43514889 |
| 60 | gamma-aminobutyric acid transport (GO:0015812) | 3.43056366 |
| 61 | stem cell development (GO:0048864) | 3.42644107 |
| 62 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.42406911 |
| 63 | catecholamine transport (GO:0051937) | 3.42182896 |
| 64 | lymph vessel development (GO:0001945) | 3.40907908 |
| 65 | aorta morphogenesis (GO:0035909) | 3.38242567 |
| 66 | regulation of platelet aggregation (GO:0090330) | 3.36901216 |
| 67 | negative regulation of stress fiber assembly (GO:0051497) | 3.32963475 |
| 68 | positive regulation of respiratory burst (GO:0060267) | 3.31496992 |
| 69 | positive regulation of phosphatase activity (GO:0010922) | 3.31404629 |
| 70 | mitotic cell cycle arrest (GO:0071850) | 3.30044060 |
| 71 | synaptic vesicle maturation (GO:0016188) | 3.29825103 |
| 72 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.29599937 |
| 73 | dermatan sulfate metabolic process (GO:0030205) | 3.28408725 |
| 74 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.25958780 |
| 75 | pH reduction (GO:0045851) | 3.25852075 |
| 76 | cellular response to ammonium ion (GO:0071242) | 3.25837006 |
| 77 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.25532708 |
| 78 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.25219329 |
| 79 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.25219329 |
| 80 | exploration behavior (GO:0035640) | 3.24506204 |
| 81 | presynaptic membrane assembly (GO:0097105) | 3.22366073 |
| 82 | serotonin metabolic process (GO:0042428) | 3.21976154 |
| 83 | neuron-neuron synaptic transmission (GO:0007270) | 3.20145483 |
| 84 | extracellular fibril organization (GO:0043206) | 3.16000378 |
| 85 | endocardial cushion morphogenesis (GO:0003203) | 3.15453610 |
| 86 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.13839450 |
| 87 | cardiac right ventricle morphogenesis (GO:0003215) | 3.13767966 |
| 88 | cGMP-mediated signaling (GO:0019934) | 3.12294513 |
| 89 | oligosaccharide biosynthetic process (GO:0009312) | 3.11687630 |
| 90 | behavioral fear response (GO:0001662) | 3.10212353 |
| 91 | behavioral defense response (GO:0002209) | 3.10212353 |
| 92 | smooth muscle tissue development (GO:0048745) | 3.10140013 |
| 93 | secretory granule organization (GO:0033363) | 3.10086511 |
| 94 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.09928891 |
| 95 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.09417701 |
| 96 | cGMP biosynthetic process (GO:0006182) | 3.08905089 |
| 97 | negative regulation of neurological system process (GO:0031645) | 3.07752283 |
| 98 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.06455479 |
| 99 | establishment of tissue polarity (GO:0007164) | 3.06055600 |
| 100 | establishment of planar polarity (GO:0001736) | 3.06055600 |
| 101 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 3.05457136 |
| 102 | glomerular filtration (GO:0003094) | 3.05283462 |
| 103 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.04980509 |
| 104 | response to histamine (GO:0034776) | 3.03626122 |
| 105 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.03441977 |
| 106 | thrombin receptor signaling pathway (GO:0070493) | 3.03285095 |
| 107 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.02090967 |
| 108 | potassium ion import (GO:0010107) | 3.01985772 |
| 109 | cellular extravasation (GO:0045123) | 2.99744498 |
| 110 | postsynaptic membrane organization (GO:0001941) | 2.98693654 |
| 111 | heart valve morphogenesis (GO:0003179) | 2.98409138 |
| 112 | auditory receptor cell differentiation (GO:0042491) | 2.98376022 |
| 113 | synaptic vesicle exocytosis (GO:0016079) | 2.97975182 |
| 114 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.97262752 |
| 115 | glomerulus development (GO:0032835) | 2.97222586 |
| 116 | phagocytosis, recognition (GO:0006910) | 2.95700805 |
| 117 | glutamate secretion (GO:0014047) | 2.95665364 |
| 118 | endosome to pigment granule transport (GO:0043485) | 2.92666684 |
| 119 | endosome to melanosome transport (GO:0035646) | 2.92666684 |
| 120 | facial nerve structural organization (GO:0021612) | 2.91917120 |
| 121 | adenosine metabolic process (GO:0046085) | 2.91383002 |
| 122 | protein localization to synapse (GO:0035418) | 2.91335129 |
| 123 | tonic smooth muscle contraction (GO:0014820) | 2.90775458 |
| 124 | regulation of postsynaptic membrane potential (GO:0060078) | 2.90071714 |
| 125 | response to interferon-alpha (GO:0035455) | 2.89887176 |
| 126 | inositol phosphate catabolic process (GO:0071545) | 2.89859958 |
| 127 | negative regulation of axon guidance (GO:1902668) | 2.89743513 |
| 128 | negative regulation of norepinephrine secretion (GO:0010700) | 2.89486341 |
| 129 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.86599504 |
| 130 | gonadal mesoderm development (GO:0007506) | 2.86530019 |
| 131 | cGMP metabolic process (GO:0046068) | 2.85231292 |
| 132 | L-fucose catabolic process (GO:0042355) | 2.84765064 |
| 133 | fucose catabolic process (GO:0019317) | 2.84765064 |
| 134 | L-fucose metabolic process (GO:0042354) | 2.84765064 |
| 135 | regulation of cilium movement (GO:0003352) | 2.83217495 |
| 136 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.82539988 |
| 137 | cell proliferation involved in metanephros development (GO:0072203) | 2.82455246 |
| 138 | locomotory exploration behavior (GO:0035641) | 2.82417875 |
| 139 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.80966047 |
| 140 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.80577973 |
| 141 | negative regulation of muscle contraction (GO:0045932) | 2.80282394 |
| 142 | behavioral response to nicotine (GO:0035095) | 2.80045429 |
| 143 | respiratory chain complex IV assembly (GO:0008535) | 2.79240106 |
| 144 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.77933877 |
| 145 | surfactant homeostasis (GO:0043129) | 2.77645418 |
| 146 | regulation of cellular respiration (GO:0043457) | 2.77632141 |
| 147 | neuronal action potential (GO:0019228) | 2.74532944 |
| 148 | primary amino compound metabolic process (GO:1901160) | 2.74313927 |
| 149 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.73883570 |
| 150 | negative regulation of androgen receptor signaling pathway (GO:0060766) | 2.73293027 |
| 151 | positive regulation of catenin import into nucleus (GO:0035413) | 2.72611263 |
| 152 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.72163290 |
| 153 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.69859358 |
| 154 | blood coagulation, intrinsic pathway (GO:0007597) | 2.69628798 |
| 155 | proline transport (GO:0015824) | 2.69452237 |
| 156 | positive regulation of catecholamine secretion (GO:0033605) | 2.67896786 |
| 157 | fear response (GO:0042596) | 2.66966885 |
| 158 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.66385100 |
| 159 | regulation of platelet activation (GO:0010543) | 2.66218690 |
| 160 | negative regulation of membrane potential (GO:0045837) | 2.65756437 |
| 161 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.65197160 |
| 162 | positive regulation of membrane potential (GO:0045838) | 2.64650676 |
| 163 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.64449981 |
| 164 | relaxation of muscle (GO:0090075) | 2.64261463 |
| 165 | parturition (GO:0007567) | 2.63653526 |
| 166 | renal filtration (GO:0097205) | 2.60614003 |
| 167 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.57328144 |
| 168 | positive regulation of actin filament depolymerization (GO:0030836) | 2.56052080 |
| 169 | nephron tubule development (GO:0072080) | 2.55146191 |
| 170 | chemical homeostasis within a tissue (GO:0048875) | 2.54796600 |
| 171 | mesenchyme morphogenesis (GO:0072132) | 2.53308220 |
| 172 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.51511094 |
| 173 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.49191567 |
| 174 | endothelium development (GO:0003158) | 2.47762031 |
| 175 | regulation of axon guidance (GO:1902667) | 2.46325230 |
| 176 | ventricular septum morphogenesis (GO:0060412) | 2.42544647 |
| 177 | regulation of hippo signaling (GO:0035330) | 2.42123533 |
| 178 | positive regulation of vasculogenesis (GO:2001214) | 2.41790865 |
| 179 | acrosome assembly (GO:0001675) | 2.39517774 |
| 180 | basement membrane organization (GO:0071711) | 2.39106417 |
| 181 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.37952024 |
| 182 | establishment of epithelial cell polarity (GO:0090162) | 2.37765947 |
| 183 | cardiac epithelial to mesenchymal transition (GO:0060317) | 2.37125936 |
| 184 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.36280875 |
| 185 | fibril organization (GO:0097435) | 2.35901034 |
| 186 | renal tubule development (GO:0061326) | 2.35830452 |
| 187 | protein neddylation (GO:0045116) | 2.35002750 |
| 188 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.34475101 |
| 189 | platelet aggregation (GO:0070527) | 2.33973577 |
| 190 | vasculature development (GO:0001944) | 2.33543490 |
| 191 | outflow tract morphogenesis (GO:0003151) | 2.33328809 |
| 192 | nephron epithelium development (GO:0072009) | 2.32765613 |
| 193 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.31520653 |
| 194 | negative regulation of protein localization to cell surface (GO:2000009) | 2.31000476 |
| 195 | cochlea development (GO:0090102) | 2.30896162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.38588567 |
| 2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.29781800 |
| 3 | TAF15_26573619_Chip-Seq_HEK293_Human | 4.27973224 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.03019818 |
| 5 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.13928827 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 2.90331085 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.87993856 |
| 8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.74746498 |
| 9 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.69547445 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 2.52702185 |
| 11 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.38585878 |
| 12 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.37473021 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.25243676 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23198928 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.14918502 |
| 16 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.14149514 |
| 17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.09093376 |
| 18 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.04467175 |
| 19 | FUS_26573619_Chip-Seq_HEK293_Human | 1.99390699 |
| 20 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.98438630 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.93861408 |
| 22 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.89019904 |
| 23 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.87759864 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.87296127 |
| 25 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.86899631 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.86504504 |
| 27 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.84439599 |
| 28 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.82336819 |
| 29 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.80566424 |
| 30 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.78319350 |
| 31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.78238838 |
| 32 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.73715779 |
| 33 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.73715779 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.73641676 |
| 35 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.72376094 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.70964779 |
| 37 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.70337975 |
| 38 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.70079659 |
| 39 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.69503295 |
| 40 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.69022284 |
| 41 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.67733417 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.64701638 |
| 43 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.63792987 |
| 44 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.62202424 |
| 45 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.61186576 |
| 46 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.61186576 |
| 47 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.60330280 |
| 48 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.59931134 |
| 49 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.59791025 |
| 50 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.58890640 |
| 51 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.56558234 |
| 52 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.54737401 |
| 53 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.54434433 |
| 54 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.53057780 |
| 55 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.52123792 |
| 56 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.50959424 |
| 57 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.49878216 |
| 58 | CJUN_26792858_Chip-Seq_BT549_Human | 1.48541402 |
| 59 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.48410669 |
| 60 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.47719642 |
| 61 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.47386026 |
| 62 | AR_25329375_ChIP-Seq_VCAP_Human | 1.41593311 |
| 63 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.41432239 |
| 64 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.40967480 |
| 65 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.40721106 |
| 66 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.40594756 |
| 67 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.39321003 |
| 68 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.37563738 |
| 69 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37512327 |
| 70 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37473450 |
| 71 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.37114477 |
| 72 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.36838240 |
| 73 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.36627130 |
| 74 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.36163944 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34364100 |
| 76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.34325834 |
| 77 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.34009202 |
| 78 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.32795881 |
| 79 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.32190970 |
| 80 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.31927220 |
| 81 | SPI1_23127762_ChIP-Seq_K562_Human | 1.31810000 |
| 82 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.31235141 |
| 83 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31229121 |
| 84 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.31000924 |
| 85 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.30386637 |
| 86 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28972321 |
| 87 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.28312071 |
| 88 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.27462012 |
| 89 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.26745986 |
| 90 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.26684239 |
| 91 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.26290472 |
| 92 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26194557 |
| 93 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.24687193 |
| 94 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24141433 |
| 95 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23433127 |
| 96 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.22421552 |
| 97 | TCF4_23295773_ChIP-Seq_U87_Human | 1.21875798 |
| 98 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21669131 |
| 99 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21136486 |
| 100 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.20220185 |
| 101 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.18076195 |
| 102 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.17757602 |
| 103 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.16988696 |
| 104 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.16566219 |
| 105 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.16049398 |
| 106 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.15927343 |
| 107 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.14388261 |
| 108 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.13751747 |
| 109 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.13657126 |
| 110 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.13275734 |
| 111 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13225310 |
| 112 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12757503 |
| 113 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12408318 |
| 114 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.09749025 |
| 115 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.08573857 |
| 116 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.08550130 |
| 117 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.08309122 |
| 118 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08053274 |
| 119 | JUN_21703547_ChIP-Seq_K562_Human | 1.06433413 |
| 120 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06222224 |
| 121 | KDM2B_26808549_Chip-Seq_REH_Human | 1.06119320 |
| 122 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.06077601 |
| 123 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05933873 |
| 124 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05727684 |
| 125 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05463719 |
| 126 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.04315420 |
| 127 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.03940981 |
| 128 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.03940981 |
| 129 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02903109 |
| 130 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01341670 |
| 131 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.01285334 |
| 132 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00720965 |
| 133 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.00470804 |
| 134 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99357144 |
| 135 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.98223051 |
| 136 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97962162 |
| 137 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.97819379 |
| 138 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.97580223 |
| 139 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97296622 |
| 140 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.96280578 |
| 141 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96266131 |
| 142 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95830170 |
| 143 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95065026 |
| 144 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.92678055 |
| 145 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91799224 |
| 146 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.91307852 |
| 147 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.89118415 |
| 148 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.87580209 |
| 149 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.87578332 |
| 150 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.87069694 |
| 151 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.85214289 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.39102513 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 4.75619092 |
| 3 | MP0003880_abnormal_central_pattern | 4.35769090 |
| 4 | MP0004272_abnormal_basement_membrane | 4.33175567 |
| 5 | MP0005503_abnormal_tendon_morphology | 4.02863014 |
| 6 | MP0002735_abnormal_chemical_nociception | 3.63828878 |
| 7 | MP0002736_abnormal_nociception_after | 3.59648175 |
| 8 | MP0009384_cardiac_valve_regurgitation | 3.56492205 |
| 9 | MP0005275_abnormal_skin_tensile | 3.45347641 |
| 10 | MP0001968_abnormal_touch/_nociception | 3.43051777 |
| 11 | MP0002822_catalepsy | 3.42469191 |
| 12 | MP0001986_abnormal_taste_sensitivity | 3.24103793 |
| 13 | MP0003279_aneurysm | 3.08566852 |
| 14 | MP0001958_emphysema | 3.05869941 |
| 15 | MP0009745_abnormal_behavioral_response | 2.91731025 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 2.79283801 |
| 17 | MP0008004_abnormal_stomach_pH | 2.67344020 |
| 18 | MP0004147_increased_porphyrin_level | 2.59518249 |
| 19 | MP0004808_abnormal_hematopoietic_stem | 2.46156779 |
| 20 | MP0003136_yellow_coat_color | 2.42277968 |
| 21 | MP0003566_abnormal_cell_adhesion | 2.38933619 |
| 22 | MP0001905_abnormal_dopamine_level | 2.25575560 |
| 23 | MP0001501_abnormal_sleep_pattern | 2.20908541 |
| 24 | MP0002272_abnormal_nervous_system | 2.17701486 |
| 25 | MP0002064_seizures | 2.10698058 |
| 26 | MP0002063_abnormal_learning/memory/cond | 2.07531433 |
| 27 | MP0001542_abnormal_bone_strength | 2.06288266 |
| 28 | MP0005171_absent_coat_pigmentation | 1.96055243 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.90998385 |
| 30 | * MP0000230_abnormal_systemic_arterial | 1.88904647 |
| 31 | MP0002572_abnormal_emotion/affect_behav | 1.87982418 |
| 32 | MP0002876_abnormal_thyroid_physiology | 1.87544420 |
| 33 | MP0002102_abnormal_ear_morphology | 1.82698094 |
| 34 | MP0008877_abnormal_DNA_methylation | 1.79537918 |
| 35 | MP0009697_abnormal_copulation | 1.74749285 |
| 36 | MP0000372_irregular_coat_pigmentation | 1.73831887 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.69805688 |
| 38 | MP0002638_abnormal_pupillary_reflex | 1.69660618 |
| 39 | MP0000534_abnormal_ureter_morphology | 1.69187164 |
| 40 | MP0005409_darkened_coat_color | 1.66158027 |
| 41 | * MP0005595_abnormal_vascular_smooth | 1.64509141 |
| 42 | MP0005174_abnormal_tail_pigmentation | 1.62168814 |
| 43 | MP0003950_abnormal_plasma_membrane | 1.61109535 |
| 44 | MP0001188_hyperpigmentation | 1.59539884 |
| 45 | MP0005164_abnormal_response_to | 1.58607389 |
| 46 | MP0000681_abnormal_thyroid_gland | 1.57572029 |
| 47 | MP0010386_abnormal_urinary_bladder | 1.56670802 |
| 48 | MP0000767_abnormal_smooth_muscle | 1.56008913 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.55877227 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.55877227 |
| 51 | MP0002733_abnormal_thermal_nociception | 1.50965374 |
| 52 | MP0005646_abnormal_pituitary_gland | 1.48142214 |
| 53 | MP0004133_heterotaxia | 1.45906291 |
| 54 | MP0002067_abnormal_sensory_capabilities | 1.43847293 |
| 55 | MP0003183_abnormal_peptide_metabolism | 1.39233046 |
| 56 | MP0006276_abnormal_autonomic_nervous | 1.37935398 |
| 57 | MP0010368_abnormal_lymphatic_system | 1.37924548 |
| 58 | MP0001970_abnormal_pain_threshold | 1.33218321 |
| 59 | MP0009780_abnormal_chondrocyte_physiolo | 1.33200646 |
| 60 | MP0003942_abnormal_urinary_system | 1.32911923 |
| 61 | MP0001664_abnormal_digestion | 1.31060224 |
| 62 | MP0009379_abnormal_foot_pigmentation | 1.28696554 |
| 63 | MP0004130_abnormal_muscle_cell | 1.26747672 |
| 64 | MP0005187_abnormal_penis_morphology | 1.24710383 |
| 65 | MP0002295_abnormal_pulmonary_circulatio | 1.22913512 |
| 66 | MP0009046_muscle_twitch | 1.22093342 |
| 67 | MP0001851_eye_inflammation | 1.20442111 |
| 68 | MP0004215_abnormal_myocardial_fiber | 1.20103779 |
| 69 | MP0004883_abnormal_blood_vessel | 1.20003112 |
| 70 | MP0005508_abnormal_skeleton_morphology | 1.19603055 |
| 71 | MP0002128_abnormal_blood_circulation | 1.17909816 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 1.15744974 |
| 73 | MP0005671_abnormal_response_to | 1.15017589 |
| 74 | MP0003787_abnormal_imprinting | 1.14933063 |
| 75 | MP0002108_abnormal_muscle_morphology | 1.14835571 |
| 76 | * MP0005620_abnormal_muscle_contractility | 1.14258070 |
| 77 | MP0002557_abnormal_social/conspecific_i | 1.12793713 |
| 78 | MP0008775_abnormal_heart_ventricle | 1.12733353 |
| 79 | MP0001348_abnormal_lacrimal_gland | 1.11120490 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 1.10365470 |
| 81 | MP0006138_congestive_heart_failure | 1.10136061 |
| 82 | MP0004510_myositis | 1.09538172 |
| 83 | MP0002396_abnormal_hematopoietic_system | 1.09487802 |
| 84 | MP0010234_abnormal_vibrissa_follicle | 1.07615273 |
| 85 | MP0004270_analgesia | 1.07613899 |
| 86 | MP0000343_altered_response_to | 1.05771036 |
| 87 | MP0005023_abnormal_wound_healing | 1.05506693 |
| 88 | MP0003879_abnormal_hair_cell | 1.05011125 |
| 89 | MP0004885_abnormal_endolymph | 1.04670811 |
| 90 | MP0001485_abnormal_pinna_reflex | 1.02471606 |
| 91 | MP0001486_abnormal_startle_reflex | 1.02300119 |
| 92 | MP0001835_abnormal_antigen_presentation | 1.01837362 |
| 93 | MP0008874_decreased_physiological_sensi | 1.01736800 |
| 94 | MP0002909_abnormal_adrenal_gland | 1.00683053 |
| 95 | MP0002734_abnormal_mechanical_nocicepti | 1.00273065 |
| 96 | MP0006036_abnormal_mitochondrial_physio | 1.00197475 |
| 97 | MP0000249_abnormal_blood_vessel | 0.99763317 |
| 98 | MP0002009_preneoplasia | 0.98969085 |
| 99 | MP0002095_abnormal_skin_pigmentation | 0.98419544 |
| 100 | MP0005551_abnormal_eye_electrophysiolog | 0.98212057 |
| 101 | MP0000516_abnormal_urinary_system | 0.96644309 |
| 102 | MP0005367_renal/urinary_system_phenotyp | 0.96644309 |
| 103 | MP0000013_abnormal_adipose_tissue | 0.96641705 |
| 104 | MP0009250_abnormal_appendicular_skeleto | 0.96432376 |
| 105 | MP0003868_abnormal_feces_composition | 0.96330981 |
| 106 | MP0002234_abnormal_pharynx_morphology | 0.95897612 |
| 107 | MP0002938_white_spotting | 0.94988513 |
| 108 | MP0003119_abnormal_digestive_system | 0.94909689 |
| 109 | MP0000685_abnormal_immune_system | 0.94640765 |
| 110 | MP0003075_altered_response_to | 0.94561730 |
| 111 | MP0005083_abnormal_biliary_tract | 0.94214292 |
| 112 | MP0004924_abnormal_behavior | 0.93688892 |
| 113 | MP0005386_behavior/neurological_phenoty | 0.93688892 |
| 114 | MP0001614_abnormal_blood_vessel | 0.93669288 |
| 115 | MP0003943_abnormal_hepatobiliary_system | 0.93531929 |
| 116 | MP0005253_abnormal_eye_physiology | 0.92214366 |
| 117 | MP0005167_abnormal_blood-brain_barrier | 0.92062503 |
| 118 | MP0006054_spinal_hemorrhage | 0.91647038 |
| 119 | MP0003866_abnormal_defecation | 0.91567831 |
| 120 | MP0008569_lethality_at_weaning | 0.90050583 |
| 121 | MP0000383_abnormal_hair_follicle | 0.89885226 |
| 122 | MP0003011_delayed_dark_adaptation | 0.89825910 |
| 123 | MP0005388_respiratory_system_phenotype | 0.88445971 |
| 124 | MP0002133_abnormal_respiratory_system | 0.88445971 |
| 125 | MP0004811_abnormal_neuron_physiology | 0.88348556 |
| 126 | MP0005085_abnormal_gallbladder_physiolo | 0.87745662 |
| 127 | MP0002184_abnormal_innervation | 0.87437861 |
| 128 | MP0001440_abnormal_grooming_behavior | 0.87378822 |
| 129 | MP0004084_abnormal_cardiac_muscle | 0.87010363 |
| 130 | MP0001324_abnormal_eye_pigmentation | 0.86334299 |
| 131 | MP0002928_abnormal_bile_duct | 0.86049082 |
| 132 | MP0009785_altered_susceptibility_to | 0.85877101 |
| 133 | MP0006292_abnormal_olfactory_placode | 0.84240270 |
| 134 | MP0002160_abnormal_reproductive_system | 0.84125813 |
| 135 | MP0005670_abnormal_white_adipose | 0.83555188 |
| 136 | MP0006035_abnormal_mitochondrial_morpho | 0.83533452 |
| 137 | MP0001661_extended_life_span | 0.83075561 |
| 138 | MP0004085_abnormal_heartbeat | 0.82407215 |
| 139 | MP0002006_tumorigenesis | 0.81866999 |
| 140 | MP0008872_abnormal_physiological_respon | 0.81855365 |
| 141 | MP0003633_abnormal_nervous_system | 0.81849523 |
| 142 | MP0009765_abnormal_xenobiotic_induced | 0.79103197 |
| 143 | MP0003724_increased_susceptibility_to | 0.78942903 |
| 144 | MP0009053_abnormal_anal_canal | 0.78666933 |
| 145 | MP0000015_abnormal_ear_pigmentation | 0.78559658 |
| 146 | MP0003638_abnormal_response/metabolism_ | 0.78293943 |
| 147 | MP0005197_abnormal_uvea_morphology | 0.76047040 |
| 148 | MP0000955_abnormal_spinal_cord | 0.75592548 |
| 149 | MP0003091_abnormal_cell_migration | 0.75396521 |
| 150 | MP0003631_nervous_system_phenotype | 0.75295953 |
| 151 | MP0001984_abnormal_olfaction | 0.74379798 |
| 152 | MP0002925_abnormal_cardiovascular_devel | 0.73509710 |
| 153 | MP0005390_skeleton_phenotype | 0.73024499 |
| 154 | MP0002166_altered_tumor_susceptibility | 0.70667225 |
| 155 | MP0005408_hypopigmentation | 0.70433669 |
| 156 | MP0004484_altered_response_of | 0.70029106 |
| 157 | MP0002115_abnormal_skeleton_extremities | 0.69522384 |
| 158 | MP0000026_abnormal_inner_ear | 0.67428253 |
| 159 | MP0000462_abnormal_digestive_system | 0.67283690 |
| 160 | MP0002398_abnormal_bone_marrow | 0.67195167 |
| 161 | MP0000049_abnormal_middle_ear | 0.67023515 |
| 162 | MP0005195_abnormal_posterior_eye | 0.66931130 |
| 163 | MP0000163_abnormal_cartilage_morphology | 0.66712439 |
| 164 | MP0000749_muscle_degeneration | 0.66599621 |
| 165 | MP0005535_abnormal_body_temperature | 0.63899697 |
| 166 | MP0003283_abnormal_digestive_organ | 0.63887529 |
| 167 | MP0001879_abnormal_lymphatic_vessel | 0.63837253 |
| 168 | MP0005423_abnormal_somatic_nervous | 0.63694302 |
| 169 | MP0005647_abnormal_sex_gland | 0.63004432 |
| 170 | MP0001765_abnormal_ion_homeostasis | 0.62986514 |
| 171 | MP0002233_abnormal_nose_morphology | 0.62612391 |
| 172 | MP0004142_abnormal_muscle_tone | 0.62547272 |
| 173 | MP0005389_reproductive_system_phenotype | 0.62267054 |
| 174 | MP0005084_abnormal_gallbladder_morpholo | 0.61747512 |
| 175 | MP0002075_abnormal_coat/hair_pigmentati | 0.59663364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased mean platelet volume (HP:0011877) | 5.55531055 |
| 2 | Focal motor seizures (HP:0011153) | 5.36391566 |
| 3 | Thrombocytosis (HP:0001894) | 5.10541211 |
| 4 | Nonprogressive disorder (HP:0003680) | 5.08124239 |
| 5 | Prolonged bleeding time (HP:0003010) | 4.58087643 |
| 6 | Annular pancreas (HP:0001734) | 4.53295785 |
| 7 | Hypothermia (HP:0002045) | 4.48810894 |
| 8 | Short hallux (HP:0010109) | 4.21308800 |
| 9 | Progressive inability to walk (HP:0002505) | 4.08398832 |
| 10 | Broad metatarsal (HP:0001783) | 4.07776714 |
| 11 | Aortic aneurysm (HP:0004942) | 4.06961799 |
| 12 | Purpura (HP:0000979) | 4.03805489 |
| 13 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.92272793 |
| 14 | Type 2 muscle fiber atrophy (HP:0003554) | 3.91988709 |
| 15 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 3.88757023 |
| 16 | Reduced antithrombin III activity (HP:0001976) | 3.84689199 |
| 17 | Petechiae (HP:0000967) | 3.79854251 |
| 18 | Aortic dissection (HP:0002647) | 3.67719813 |
| 19 | Congenital, generalized hypertrichosis (HP:0004540) | 3.63450504 |
| 20 | Muscle fiber atrophy (HP:0100295) | 3.53305369 |
| 21 | IgM deficiency (HP:0002850) | 3.47641040 |
| 22 | Premature rupture of membranes (HP:0001788) | 3.37443798 |
| 23 | Hypoplastic ischia (HP:0003175) | 3.36727027 |
| 24 | Spontaneous abortion (HP:0005268) | 3.32568518 |
| 25 | Abnormality of the ischium (HP:0003174) | 3.27983465 |
| 26 | Soft skin (HP:0000977) | 3.26406747 |
| 27 | Febrile seizures (HP:0002373) | 3.26297599 |
| 28 | Myokymia (HP:0002411) | 3.22223748 |
| 29 | Type II lissencephaly (HP:0007260) | 3.21876934 |
| 30 | Pulmonary artery stenosis (HP:0004415) | 3.20706882 |
| 31 | Gonadotropin excess (HP:0000837) | 3.20129139 |
| 32 | Ragged-red muscle fibers (HP:0003200) | 3.19334143 |
| 33 | Increased corneal curvature (HP:0100692) | 3.12161382 |
| 34 | Keratoconus (HP:0000563) | 3.12161382 |
| 35 | Impaired platelet aggregation (HP:0003540) | 3.11986131 |
| 36 | Abnormal platelet function (HP:0011869) | 3.11986131 |
| 37 | Thyroid-stimulating hormone excess (HP:0002925) | 3.08823414 |
| 38 | Visual hallucinations (HP:0002367) | 3.08347809 |
| 39 | Increased IgE level (HP:0003212) | 3.08328815 |
| 40 | Poor suck (HP:0002033) | 3.07595672 |
| 41 | Weak cry (HP:0001612) | 3.05709740 |
| 42 | Chorioretinal atrophy (HP:0000533) | 2.97336024 |
| 43 | Congenital stationary night blindness (HP:0007642) | 2.94311207 |
| 44 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.85878568 |
| 45 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.85878568 |
| 46 | Scotoma (HP:0000575) | 2.84848869 |
| 47 | Focal seizures (HP:0007359) | 2.84773404 |
| 48 | Inability to walk (HP:0002540) | 2.84524851 |
| 49 | Amblyopia (HP:0000646) | 2.83597782 |
| 50 | Prominent supraorbital ridges (HP:0000336) | 2.81042493 |
| 51 | Lower limb asymmetry (HP:0100559) | 2.80965441 |
| 52 | Anterior segment dysgenesis (HP:0007700) | 2.75298501 |
| 53 | Ulnar claw (HP:0001178) | 2.74307828 |
| 54 | Hyperlipoproteinemia (HP:0010980) | 2.70416392 |
| 55 | Epileptic encephalopathy (HP:0200134) | 2.67434150 |
| 56 | Bone cyst (HP:0012062) | 2.66677432 |
| 57 | Arterial thrombosis (HP:0004420) | 2.61589721 |
| 58 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.61174242 |
| 59 | Epistaxis (HP:0000421) | 2.59653743 |
| 60 | Gaze-evoked nystagmus (HP:0000640) | 2.55263230 |
| 61 | Mitral stenosis (HP:0001718) | 2.55221532 |
| 62 | Increased intramyocellular lipid droplets (HP:0012240) | 2.47555590 |
| 63 | Hemiplegia (HP:0002301) | 2.46289082 |
| 64 | Menorrhagia (HP:0000132) | 2.44229518 |
| 65 | Type I transferrin isoform profile (HP:0003642) | 2.43311275 |
| 66 | Hypoplasia of the iris (HP:0007676) | 2.42617523 |
| 67 | Hemiparesis (HP:0001269) | 2.40377209 |
| 68 | Protrusio acetabuli (HP:0003179) | 2.40117061 |
| 69 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.39635090 |
| 70 | Hypoproteinemia (HP:0003075) | 2.38344955 |
| 71 | Preaxial foot polydactyly (HP:0001841) | 2.37589912 |
| 72 | Abnormality of midbrain morphology (HP:0002418) | 2.36396035 |
| 73 | Molar tooth sign on MRI (HP:0002419) | 2.36396035 |
| 74 | Aplastic anemia (HP:0001915) | 2.32928281 |
| 75 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.32647730 |
| 76 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.32647730 |
| 77 | Abnormal protein glycosylation (HP:0012346) | 2.32647730 |
| 78 | Abnormal glycosylation (HP:0012345) | 2.32647730 |
| 79 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.31442707 |
| 80 | Spontaneous hematomas (HP:0007420) | 2.28957908 |
| 81 | Atonic seizures (HP:0010819) | 2.27943602 |
| 82 | Blue irides (HP:0000635) | 2.25928110 |
| 83 | Vertebral arch anomaly (HP:0008438) | 2.24309226 |
| 84 | Large for gestational age (HP:0001520) | 2.19885976 |
| 85 | Follicular hyperkeratosis (HP:0007502) | 2.19867375 |
| 86 | Striae distensae (HP:0001065) | 2.16307688 |
| 87 | Bladder diverticulum (HP:0000015) | 2.16282826 |
| 88 | Patchy hypopigmentation of hair (HP:0011365) | 2.14730071 |
| 89 | Abnormality of the anterior chamber (HP:0000593) | 2.14716714 |
| 90 | Heterochromia iridis (HP:0001100) | 2.12691523 |
| 91 | Acute lymphatic leukemia (HP:0006721) | 2.11687569 |
| 92 | Neoplasm of the heart (HP:0100544) | 2.10798955 |
| 93 | Neonatal short-limb short stature (HP:0008921) | 2.10749985 |
| 94 | Palpebral edema (HP:0100540) | 2.10578649 |
| 95 | Amaurosis fugax (HP:0100576) | 2.10410986 |
| 96 | Protruding tongue (HP:0010808) | 2.09909042 |
| 97 | Abnormality of the columella (HP:0009929) | 2.09728019 |
| 98 | Pancreatic fibrosis (HP:0100732) | 2.09417878 |
| 99 | Dyskinesia (HP:0100660) | 2.09031167 |
| 100 | Enlarged penis (HP:0000040) | 2.05491995 |
| 101 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.03595009 |
| 102 | Aortic valve stenosis (HP:0001650) | 2.02535692 |
| 103 | Cerebral aneurysm (HP:0004944) | 2.02272959 |
| 104 | Spinal canal stenosis (HP:0003416) | 2.01660619 |
| 105 | Abnormal platelet volume (HP:0011876) | 2.01320701 |
| 106 | Fetal akinesia sequence (HP:0001989) | 1.99238006 |
| 107 | Metaphyseal dysplasia (HP:0100255) | 1.99225340 |
| 108 | Decreased central vision (HP:0007663) | 1.98980927 |
| 109 | Gingival bleeding (HP:0000225) | 1.98575545 |
| 110 | Vertebral compression fractures (HP:0002953) | 1.97958900 |
| 111 | Wide anterior fontanel (HP:0000260) | 1.96631835 |
| 112 | Retinal dysplasia (HP:0007973) | 1.96216897 |
| 113 | Vascular tortuosity (HP:0004948) | 1.94691730 |
| 114 | Accelerated skeletal maturation (HP:0005616) | 1.94057143 |
| 115 | Long nose (HP:0003189) | 1.93703474 |
| 116 | Zonular cataract (HP:0010920) | 1.93618701 |
| 117 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.92914487 |
| 118 | Hyperpituitarism (HP:0010514) | 1.91900227 |
| 119 | Overgrowth (HP:0001548) | 1.91892276 |
| 120 | Hyperventilation (HP:0002883) | 1.91751625 |
| 121 | Syringomyelia (HP:0003396) | 1.91101281 |
| 122 | Spinal cord lesions (HP:0100561) | 1.91101281 |
| 123 | Interstitial pulmonary disease (HP:0006530) | 1.90178711 |
| 124 | Intestinal atresia (HP:0011100) | 1.89407039 |
| 125 | Abnormality of the renal medulla (HP:0100957) | 1.88993346 |
| 126 | Peritonitis (HP:0002586) | 1.88776104 |
| 127 | Short tibia (HP:0005736) | 1.88768799 |
| 128 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.87995473 |
| 129 | Postural instability (HP:0002172) | 1.87227254 |
| 130 | 3-Methylglutaconic aciduria (HP:0003535) | 1.86959971 |
| 131 | Depressed nasal tip (HP:0000437) | 1.85569096 |
| 132 | Broad-based gait (HP:0002136) | 1.85131731 |
| 133 | Scanning speech (HP:0002168) | 1.84343856 |
| 134 | Ankle contracture (HP:0006466) | 1.83552305 |
| 135 | Limb dystonia (HP:0002451) | 1.83481963 |
| 136 | Tubulointerstitial fibrosis (HP:0005576) | 1.82524228 |
| 137 | Abnormality of the nasal mucosa (HP:0000433) | 1.82213364 |
| 138 | Congenital sensorineural hearing impairment (HP:0008527) | 1.81605115 |
| 139 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.81517670 |
| 140 | Short 4th metacarpal (HP:0010044) | 1.81517670 |
| 141 | Hepatocellular necrosis (HP:0001404) | 1.81345618 |
| 142 | Type 1 muscle fiber predominance (HP:0003803) | 1.81165945 |
| 143 | Coronal craniosynostosis (HP:0004440) | 1.81153019 |
| 144 | Pancreatic cysts (HP:0001737) | 1.81024925 |
| 145 | Abnormality of the neuromuscular junction (HP:0003398) | 1.79943619 |
| 146 | Fatigable weakness (HP:0003473) | 1.79943619 |
| 147 | Gingival overgrowth (HP:0000212) | 1.79813543 |
| 148 | Increased muscle lipid content (HP:0009058) | 1.78338464 |
| 149 | Bruising susceptibility (HP:0000978) | 1.78302653 |
| 150 | Hypoventilation (HP:0002791) | 1.77913008 |
| 151 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.77271628 |
| 152 | Hypoplasia of the fovea (HP:0007750) | 1.77271628 |
| 153 | Chest pain (HP:0100749) | 1.76055092 |
| 154 | Venous insufficiency (HP:0005293) | 1.74624548 |
| 155 | Stereotypic behavior (HP:0000733) | 1.74170133 |
| 156 | Renal dysplasia (HP:0000110) | 1.73626948 |
| 157 | Abnormality of the renal collecting system (HP:0004742) | 1.71417145 |
| 158 | Long toe (HP:0010511) | 1.71295001 |
| 159 | Abnormal hair whorl (HP:0010721) | 1.71226992 |
| 160 | Dialeptic seizures (HP:0011146) | 1.70853103 |
| 161 | Conjunctival telangiectasia (HP:0000524) | 1.70746605 |
| 162 | Ectopia lentis (HP:0001083) | 1.70225665 |
| 163 | True hermaphroditism (HP:0010459) | 1.70002139 |
| 164 | Abnormal number of erythroid precursors (HP:0012131) | 1.69994868 |
| 165 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.67747311 |
| 166 | Bulbous nose (HP:0000414) | 1.67078353 |
| 167 | Chronic hepatic failure (HP:0100626) | 1.66615265 |
| 168 | Abnormality of dentin (HP:0010299) | 1.66613982 |
| 169 | Thyroiditis (HP:0100646) | 1.64685139 |
| 170 | Nuclear cataract (HP:0100018) | 1.64263050 |
| 171 | Nephronophthisis (HP:0000090) | 1.64012324 |
| 172 | Large eyes (HP:0001090) | 1.63409041 |
| 173 | Shallow orbits (HP:0000586) | 1.63302181 |
| 174 | Redundant skin (HP:0001582) | 1.62271486 |
| 175 | Central scotoma (HP:0000603) | 1.61606181 |
| 176 | Atrophic scars (HP:0001075) | 1.61299143 |
| 177 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.61248659 |
| 178 | Osteoarthritis (HP:0002758) | 1.60647728 |
| 179 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.59388758 |
| 180 | Severe Myopia (HP:0011003) | 1.59232533 |
| 181 | Decreased skull ossification (HP:0004331) | 1.58629506 |
| 182 | Papillary thyroid carcinoma (HP:0002895) | 1.57575536 |
| 183 | Broad hallux (HP:0010055) | 1.56383134 |
| 184 | Esotropia (HP:0000565) | 1.55679042 |
| 185 | Chronic otitis media (HP:0000389) | 1.55264159 |
| 186 | Growth hormone excess (HP:0000845) | 1.53551858 |
| 187 | Thyroid carcinoma (HP:0002890) | 1.53041659 |
| 188 | Generalized hypopigmentation of hair (HP:0011358) | 1.52565163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 3.92163039 |
| 2 | MAPK15 | 3.72348343 |
| 3 | MUSK | 3.72323980 |
| 4 | NTRK3 | 3.68462083 |
| 5 | TIE1 | 2.92477366 |
| 6 | EIF2AK1 | 2.89211324 |
| 7 | PNCK | 2.73425058 |
| 8 | CAMKK2 | 2.49847457 |
| 9 | PRPF4B | 2.35016334 |
| 10 | TAF1 | 2.32423636 |
| 11 | EPHA4 | 2.23323091 |
| 12 | STK39 | 2.08763178 |
| 13 | SIK3 | 2.05465168 |
| 14 | TNK2 | 2.01501777 |
| 15 | NUAK1 | 2.01145182 |
| 16 | FRK | 1.97557656 |
| 17 | DAPK1 | 1.94725812 |
| 18 | MKNK1 | 1.85722955 |
| 19 | PINK1 | 1.83754977 |
| 20 | MST4 | 1.81528938 |
| 21 | BMPR1B | 1.81188519 |
| 22 | EIF2AK3 | 1.77929033 |
| 23 | FES | 1.75864499 |
| 24 | ADRBK1 | 1.74711221 |
| 25 | TAOK3 | 1.74552960 |
| 26 | STK16 | 1.73109413 |
| 27 | MAP3K13 | 1.71409457 |
| 28 | CDK19 | 1.71087437 |
| 29 | EPHB2 | 1.70078062 |
| 30 | NTRK1 | 1.64953255 |
| 31 | BRD4 | 1.63007141 |
| 32 | MAP3K9 | 1.58037116 |
| 33 | PIK3CG | 1.57895695 |
| 34 | DDR2 | 1.57460165 |
| 35 | EPHA3 | 1.56383078 |
| 36 | OXSR1 | 1.54213420 |
| 37 | CDK8 | 1.53972872 |
| 38 | MAP2K6 | 1.52756906 |
| 39 | LATS1 | 1.51916459 |
| 40 | MAPKAPK5 | 1.51257161 |
| 41 | PDGFRB | 1.43759360 |
| 42 | KSR2 | 1.43563553 |
| 43 | MYLK | 1.37670545 |
| 44 | FGFR3 | 1.35970854 |
| 45 | KIT | 1.35797875 |
| 46 | TXK | 1.35664350 |
| 47 | STK38L | 1.35642191 |
| 48 | TNIK | 1.35235161 |
| 49 | MATK | 1.33330762 |
| 50 | PAK3 | 1.31291339 |
| 51 | ARAF | 1.27327062 |
| 52 | MAP4K1 | 1.27249840 |
| 53 | PAK2 | 1.26705637 |
| 54 | TGFBR1 | 1.22376270 |
| 55 | MAPK7 | 1.20177478 |
| 56 | WEE1 | 1.18851704 |
| 57 | CASK | 1.17494399 |
| 58 | CSNK1G3 | 1.12360899 |
| 59 | SYK | 1.11992249 |
| 60 | BTK | 1.11663489 |
| 61 | CAMK1 | 1.10065269 |
| 62 | CCNB1 | 1.08306956 |
| 63 | VRK1 | 1.04659400 |
| 64 | RAF1 | 1.01607444 |
| 65 | MAP3K2 | 1.01295952 |
| 66 | NTRK2 | 1.01002318 |
| 67 | KSR1 | 1.00615135 |
| 68 | MAP2K3 | 1.00323540 |
| 69 | MKNK2 | 0.99625008 |
| 70 | MAPKAPK3 | 0.96762469 |
| 71 | GRK5 | 0.94652713 |
| 72 | STK3 | 0.94433778 |
| 73 | TGFBR2 | 0.94297482 |
| 74 | GSK3A | 0.91754206 |
| 75 | ADRBK2 | 0.91724035 |
| 76 | MAPK13 | 0.91267123 |
| 77 | CSNK1G1 | 0.90120554 |
| 78 | JAK3 | 0.89916902 |
| 79 | BMX | 0.89768141 |
| 80 | BRSK2 | 0.88433794 |
| 81 | PTK2B | 0.87559570 |
| 82 | FER | 0.86816977 |
| 83 | WNK3 | 0.86522726 |
| 84 | PRKD1 | 0.86271200 |
| 85 | BCKDK | 0.84659155 |
| 86 | MAP2K7 | 0.84614234 |
| 87 | LYN | 0.83543999 |
| 88 | CSNK1G2 | 0.82366056 |
| 89 | MAP4K2 | 0.82197102 |
| 90 | CAMKK1 | 0.82195192 |
| 91 | NME2 | 0.81354962 |
| 92 | ILK | 0.80536118 |
| 93 | PDK2 | 0.78256168 |
| 94 | ROCK1 | 0.78194527 |
| 95 | ACVR1B | 0.74301098 |
| 96 | IRAK1 | 0.74158953 |
| 97 | TSSK6 | 0.72682884 |
| 98 | DMPK | 0.72587734 |
| 99 | ABL2 | 0.71868818 |
| 100 | PLK2 | 0.71850180 |
| 101 | MAP2K4 | 0.71377154 |
| 102 | PDGFRA | 0.70008377 |
| 103 | PDK1 | 0.69578432 |
| 104 | PRKD2 | 0.69188292 |
| 105 | TEC | 0.68862396 |
| 106 | HIPK2 | 0.68339333 |
| 107 | MAP3K1 | 0.66881907 |
| 108 | NEK9 | 0.66695473 |
| 109 | LMTK2 | 0.65061666 |
| 110 | BMPR2 | 0.64200813 |
| 111 | EIF2AK2 | 0.64044864 |
| 112 | PRKG2 | 0.63952113 |
| 113 | HCK | 0.63915477 |
| 114 | MAPK12 | 0.62715961 |
| 115 | MET | 0.62373855 |
| 116 | ERBB3 | 0.62043770 |
| 117 | MAP2K1 | 0.60738240 |
| 118 | DYRK1A | 0.59696182 |
| 119 | PRKCH | 0.58721689 |
| 120 | CAMK2A | 0.57208910 |
| 121 | MARK1 | 0.56386244 |
| 122 | * PRKG1 | 0.56271713 |
| 123 | MINK1 | 0.55632655 |
| 124 | TRPM7 | 0.53257829 |
| 125 | PRKCG | 0.53019602 |
| 126 | DAPK3 | 0.51861551 |
| 127 | PRKACA | 0.51716597 |
| 128 | DYRK2 | 0.50845977 |
| 129 | CAMK2B | 0.50648653 |
| 130 | ZAP70 | 0.50360455 |
| 131 | PIK3CA | 0.49261734 |
| 132 | PKN1 | 0.47542095 |
| 133 | PLK3 | 0.47216482 |
| 134 | DAPK2 | 0.47210607 |
| 135 | CDC42BPA | 0.46846637 |
| 136 | RPS6KA2 | 0.46572152 |
| 137 | STK11 | 0.46307364 |
| 138 | DYRK1B | 0.45106233 |
| 139 | LCK | 0.44878815 |
| 140 | FGFR2 | 0.44386680 |
| 141 | WNK4 | 0.44154409 |
| 142 | PRKCA | 0.43033779 |
| 143 | NME1 | 0.42849885 |
| 144 | KDR | 0.41382623 |
| 145 | RPS6KB1 | 0.41208176 |
| 146 | GRK1 | 0.40419333 |
| 147 | INSR | 0.39962414 |
| 148 | PRKCZ | 0.39723284 |
| 149 | AKT3 | 0.39387094 |
| 150 | ABL1 | 0.38890426 |
| 151 | MOS | 0.38673521 |
| 152 | MAPK4 | 0.38088980 |
| 153 | YES1 | 0.37948988 |
| 154 | CDK3 | 0.37866054 |
| 155 | CDK5 | 0.35616959 |
| 156 | SGK2 | 0.35327964 |
| 157 | RET | 0.35293893 |
| 158 | CSF1R | 0.34907743 |
| 159 | GRK6 | 0.34502250 |
| 160 | PRKCE | 0.33499876 |
| 161 | IGF1R | 0.33432350 |
| 162 | PDPK1 | 0.32687099 |
| 163 | FLT3 | 0.32600672 |
| 164 | TAOK2 | 0.32350148 |
| 165 | PRKACG | 0.31229570 |
| 166 | MAP3K7 | 0.28925835 |
| 167 | CDK9 | 0.28861694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 4.59156727 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.83490142 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.89858511 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.79561398 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.66656822 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.62853704 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.62449128 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.45027212 |
| 9 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.34490169 |
| 10 | Taste transduction_Homo sapiens_hsa04742 | 2.21608071 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.16605992 |
| 12 | Focal adhesion_Homo sapiens_hsa04510 | 2.10840790 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.06944429 |
| 14 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.04196450 |
| 15 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.04163184 |
| 16 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.02435240 |
| 17 | GABAergic synapse_Homo sapiens_hsa04727 | 1.98280727 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 1.98124710 |
| 19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.95973888 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.95882453 |
| 21 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.94439305 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.91910749 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.91223926 |
| 24 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.82656508 |
| 25 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.81730147 |
| 26 | Ribosome_Homo sapiens_hsa03010 | 1.79881238 |
| 27 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.75945588 |
| 28 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.67491300 |
| 29 | Platelet activation_Homo sapiens_hsa04611 | 1.66822927 |
| 30 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.65234582 |
| 31 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.58727204 |
| 32 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.51655967 |
| 33 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.50810523 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.48458139 |
| 35 | Sulfur relay system_Homo sapiens_hsa04122 | 1.47616339 |
| 36 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.47478225 |
| 37 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.45788043 |
| 38 | Renin secretion_Homo sapiens_hsa04924 | 1.44400509 |
| 39 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.39822615 |
| 40 | Phototransduction_Homo sapiens_hsa04744 | 1.38496335 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.37773148 |
| 42 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.32985797 |
| 43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.31211448 |
| 44 | Cocaine addiction_Homo sapiens_hsa05030 | 1.29047396 |
| 45 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.28822879 |
| 46 | Insulin secretion_Homo sapiens_hsa04911 | 1.28122401 |
| 47 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.28101253 |
| 48 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.22393043 |
| 49 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.20681117 |
| 50 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.20074414 |
| 51 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.19005750 |
| 52 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.18943104 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.11679024 |
| 54 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.11402534 |
| 55 | Amoebiasis_Homo sapiens_hsa05146 | 1.09003981 |
| 56 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.08501554 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.06976972 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.06757119 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06701512 |
| 60 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.06386630 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.05366217 |
| 62 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.02631897 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.02579672 |
| 64 | Thyroid cancer_Homo sapiens_hsa05216 | 1.00942293 |
| 65 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.99399358 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98530609 |
| 67 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.97194468 |
| 68 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.93366281 |
| 69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.91239551 |
| 70 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.91192550 |
| 71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.90850464 |
| 72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.90694800 |
| 73 | Gap junction_Homo sapiens_hsa04540 | 0.89938880 |
| 74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87036083 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.84787092 |
| 76 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.84629286 |
| 77 | Mineral absorption_Homo sapiens_hsa04978 | 0.84414481 |
| 78 | Histidine metabolism_Homo sapiens_hsa00340 | 0.84346458 |
| 79 | RNA degradation_Homo sapiens_hsa03018 | 0.82129728 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82082690 |
| 81 | Adherens junction_Homo sapiens_hsa04520 | 0.81182092 |
| 82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.81000556 |
| 83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.78462211 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77242533 |
| 85 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.76632334 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76028179 |
| 87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75990856 |
| 88 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.75519563 |
| 89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.74922707 |
| 90 | Pathways in cancer_Homo sapiens_hsa05200 | 0.74508722 |
| 91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74237288 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.74206260 |
| 93 | Glioma_Homo sapiens_hsa05214 | 0.73792424 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.73282240 |
| 95 | Retinol metabolism_Homo sapiens_hsa00830 | 0.71150052 |
| 96 | Purine metabolism_Homo sapiens_hsa00230 | 0.70440063 |
| 97 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68642102 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67169659 |
| 99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66618658 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.66595098 |
| 101 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.66296724 |
| 102 | Melanoma_Homo sapiens_hsa05218 | 0.66208105 |
| 103 | Homologous recombination_Homo sapiens_hsa03440 | 0.66048244 |
| 104 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.64263633 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63128507 |
| 106 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.62839444 |
| 107 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60783847 |
| 108 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59908978 |
| 109 | Melanogenesis_Homo sapiens_hsa04916 | 0.59845018 |
| 110 | Tight junction_Homo sapiens_hsa04530 | 0.58923221 |
| 111 | Basal transcription factors_Homo sapiens_hsa03022 | 0.57017931 |
| 112 | Bile secretion_Homo sapiens_hsa04976 | 0.56576477 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56541691 |
| 114 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56125809 |
| 115 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.55431556 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54200687 |
| 117 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53973668 |
| 118 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.53425332 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.53090949 |
| 120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53027410 |
| 121 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.52203182 |
| 122 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50706633 |
| 123 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49851966 |
| 124 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.49341670 |
| 125 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.48945426 |
| 126 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47722040 |
| 127 | Parkinsons disease_Homo sapiens_hsa05012 | 0.47373987 |
| 128 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47234680 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46403165 |
| 130 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44483307 |
| 131 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.42837202 |
| 132 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42299562 |
| 133 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42002644 |
| 134 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.41584234 |
| 135 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40012039 |
| 136 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39494373 |
| 137 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.38163756 |
| 138 | ABC transporters_Homo sapiens_hsa02010 | 0.37425413 |
| 139 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36418062 |
| 140 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36305880 |
| 141 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33615455 |
| 142 | Axon guidance_Homo sapiens_hsa04360 | 0.32833623 |
| 143 | DNA replication_Homo sapiens_hsa03030 | 0.30058954 |
| 144 | Protein export_Homo sapiens_hsa03060 | 0.29596137 |
| 145 | Alcoholism_Homo sapiens_hsa05034 | 0.29496579 |
| 146 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28449450 |
| 147 | Alzheimers disease_Homo sapiens_hsa05010 | 0.28412930 |
| 148 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.28338470 |
| 149 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.27636202 |
| 150 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.26985152 |

